REQUEST A DEMO
Total
USD $0.00
Search more companies

Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac A.S. (Turkiye)

Main Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac Sanayi Anonim Sirketi Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac A.S. is based in Turkiye, with the head office in Istanbul. It operates in the Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers sector. 44 (2024) employees currently work for Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac A.S.. From the latest financial highlights, Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac A.S. reported a net sales revenue increase of 316.86% in 2022. A growth of 124.21% was recorded in its total assets. The net profit margin of Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac A.S. increased by 19.22% in 2022.

Headquarters
B Blok Sitesi Mert Plaza D:9 No:5-7 Aydinevler Mahallesi Aslanbey Caddesi Maltepe
Istanbul; Marmara; Postal Code: 34854

Contact Details: Purchase the Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac A.S. report to view the information.

Website: http://www.vsy.com.tr

Basic Information
Total Employees:
Purchase the Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac A.S. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Vsy Tr Biyoteknoloji Biyomedikal Ve Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
316.86%
Total operating revenue
316.86%
Operating profit (EBIT)
1796.21%
Net Profit (Loss) for the Period
55.48%
Total assets
124.21%
Total equity
-43.15%
Operating Profit Margin (ROS)
11.77%
Net Profit Margin
19.22%
Return on Equity (ROE)
-66.79%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?